Month: December 2021

The U.S. Centers for Disease Control and Prevention on Friday issued guidelines for keeping children in school even if they are unvaccinated or partially vaccinated and have been exposed to someone with COVID-19.

During a virtual briefing by the White House COVID-19 response team, CDC Director Rochelle Walensky said the test-to-stay protocol involves testing twice in a seven-day period anyone who has had close contact with someone infected with COVID-19. She said if exposed children meet certain criteria and continue to test negative, they can stay in school instead of quarantining at home.

Walensky said numerous jurisdictions have been experimenting with test-to-stay strategies. Some were testing every day, some every other day, and some twice a week. From those experiments, she said, the CDC will recommend no less than twice-weekly testing to adequately adhere to test-to-stay protocols.

The CDC also published studies conducted in the United States and internationally that looked at how COVID-19 is spread in schools, which helped form the basis for test-to-stay recommendations.

Walensky reported at least 39 U.S. states have more than 75 confirmed cases involving the omicron variant. She said the delta variant continues to circulate widely and remains the dominant strain in the United States, but omicron is spreading rapidly and is expected to become the dominant strain in the coming weeks.

The CDC director said omicron has been found among those who are vaccinated and boosted, and health officials believe these cases are milder or asymptomatic because of vaccine protection. “What we do know is we have the tools to protect ourselves against COVID-19,” she said.

White House Coronavirus Response Coordinator Jeff Zients said the U.S. is fully prepared to confront the variant, with ample supplies of vaccines and boosters.

“This is not a moment to panic, because we know how to protect people,” Zients said. “And we have the tools to do it.”

Some information for this report came from The Associated Press and Reuters,
…

Japanese Prime Minister Fumio Kishida said Friday his government is seeking to accelerate its COVID-19 booster shots campaign and has reached out to the head of U.S. pharmaceutical company Pfizer to secure additional vaccines.

Kishida told reporters the government has been negotiating to receive 120 million doses of Pfizer’s COVID-19 vaccine ahead of schedule. He said during his call with the company’s CEO, Albert Bourla, he also agreed to purchase two million doses of Pfizer’s oral COVID-19 treatment, Paxlovid.

The government started arrangements Thursday to adjust the timeframe for workers and patients in elder-care facilities to receive booster shots to six months after their second shots. Health officials shortened the original eight-month timeline between initial vaccinations and booster shots after the discovery of the new omicron variant of coronavirus, the virus that causes COVID-19.

Japan has confirmed a handful of omicron variant cases. The Tokyo Metropolitan Government confirmed on Friday that a man in his 20s who attended a soccer match near the capital was found positive for omicron.

Japanese Chief Cabinet Secretary Hirokazu Matsuno also confirmed 70 coronavirus cases have been found at the U.S. Camp Hansen military base in the southern island prefecture of Okinawa.

Matsuno said the Japanese government has urged U.S. officials there to thoroughly quarantine infected persons, identify close contacts at an early stage, and strengthen measures to prevent the spread of infection.

Some information for this report was provided by The Associated Press and Reuters.
…

After internal Facebook documents were shared widely with news organizations, the question remains whether and how Facebook will change. Michelle Quinn reports.
…

China and Russia have begun collaborating on technology to rival the United States’ GPS and European Galileo satellite navigation systems, as the two countries pursue closer military and strategic ties.

Earlier this year, China agreed to host ground monitoring stations for Russia’s GLONASS positioning system on its soil, which improves global range and accuracy but can pose a security risk. In turn, Russia agreed to host ground stations for China’s BeiDou system.

The reciprocal agreement indicates a growing level of trust and cooperation between Moscow and Beijing, says analyst Alexander Gabuev, senior fellow and chair of the Russia in the Asia-Pacific Program at the Carnegie Moscow Center.

“Russia’s schism with the West and deepening confrontation and competition between China and the U.S. as two superpowers is definitely contributing to rapprochement between Moscow and Beijing. There is a natural economic complementarity where Russia has (an) abundance of natural resources, and China has capital and technology to develop those resources. And finally, both are authoritarian states, so they don’t have this allergy when talking domestic political setup, or the poisoning of (Russian opposition leader) Alexi Navalny, or issues like Hong Kong or human rights in Xinjiang,” Gabuev told VOA.

It will take some time for the collaboration on satellite navigation systems to be felt on the ground.

“So far, we have yet to see important results, because in Russia, Russia still relies increasingly on GLONASS but also on GPS. We don’t have major BeiDou-linked projects,” Gabuev added.

Satellites

Satellites are seen as a crucial component of 21st century military power. Last month, Russia tested a missile against one of its own satellites. The U.S. said the resulting debris threatened astronauts on the International Space Station.

“What’s most troubling about that is the danger that it creates for the international community. It undermines strategic stability,” U.S. Secretary of Defense Lloyd Austin told reporters Nov. 17.

Russia, China and the U.S. are among several nations developing hypersonic missiles, which travel through the upper atmosphere at up to five times the speed of sound.

Space treaty

Russian Foreign Minister Sergei Lavrov said the U.S. had failed to engage on a joint Russian-Chinese space treaty.

“They have ignored for many years the initiative of Russia and China to prepare a treaty to prevent an arms race in space. They simply ignore it, insisting instead on developing some sort of universal rules,” Lavrov said.

In an interview June 11 with U.S. broadcaster NBC, Russian President Vladimir Putin said cooperation with Beijing was deepening.

“We have been working and will continue to work with China, which applies to all kinds of programs, including exploring deep space. And I think there is nothing but positive information here. Frankly, I don’t see any contradictions here,” Putin said.

There are limits to Russian and Chinese cooperation, Gabuev said.

“Both Russia and China are religious about their strategic autonomy. There is deep-seated nationalism, there is some level of mistrust and some level of competition in many of those areas where there is seeming complementarity, like space programs. I think that these advances in military technology is happening mostly in parallel, but not jointly.”

India

Gabuev notes that Russia has worked more closely with India than China, including on the development of the joint BrahMos cruise missile system since the 1990s.

“Russia felt secure enough to develop BrahMos missiles together with Indian colleagues. So, this military cooperation between Russia and China is deepening, it’s definitely causing a significant challenge to the West, particularly because it helps the PLA (China’s People’s Liberation Army) to become a really 21st century fighting power and a global military power. But at the same time, we don’t see the depth that exists between, for example, the U.S. and America’s allies,” Gabuev said.

India has also purchased Russia’s S-400 missile defense system, an attempt to counter China’s military might that also risks angering Delhi’s ally, the United States, and an indication of the complexity of strategic relations in a changing world order. 

 
…

The U.S. government on Thursday permanently eased some restrictions on a pill used to terminate early pregnancies, allowing the drug to be sent by mail rather than requiring it to be dispensed in person.

The decision by the Food and Drug Administration comes as the right to obtain an abortion, established in the 1973 Supreme Court ruling Roe v. Wade hangs in the balance.

The medication, generically known as mifepristone, is approved for use up to 10 weeks of pregnancy and is also sometimes prescribed to treat women who are having miscarriages.

“The FDA’s decision will come as a tremendous relief for countless abortion and miscarriage patients,” said Georgeanne Usova, senior legislative counsel at the American Civil Liberties Union.

The restrictions on the pill had been in place since the FDA approved the drug in 2000 and were lifted temporarily by the government earlier this year because of the pandemic. That enabled women to consult health care providers by telemedicine and receive the pills by mail. The FDA’s decision makes that temporary change permanent.

As a result of the FDA rule change, many patients will not need to go to a clinic, medical office or hospital in person to receive the medication but can opt to receive the pill through the mail from a certified prescriber or pharmacy.

The decision will increase access to medication abortion for women in remote and rural areas without providers nearby.

Low-income women who face obstacles reaching clinics such as lack of transportation and inability to take time off work will also gain greater access to the drug.

However, 19 states including Texas have laws that supersede the FDA decision by barring telehealth consultations or the mailing of abortion pills. Women in those states would not be able to make use of the rule change at home but could potentially travel to other states to obtain medication abortion.

States such as California and New York that have sought to strengthen access to abortion may make the drug available to women from other states.

The change is likely to add to the intense U.S. political debate over abortion. Conservative Supreme Court justices indicated in December 1 oral arguments over an abortion ban in Mississippi at 15 weeks of pregnancy that they were open to either gutting Roe or overturning it entirely. A decision is due by the end of June.

The Charlotte Lozier Institute and Susan B. Anthony List, which advocate against abortion, said in a statement that the FDA decision ignored data on complications and put women at risk.

The groups called on the FDA to restore the in-person dispensing requirement and add restrictions.

FDA records show that of the 3.7 million women who took Mifeprex, the branded version of the drug, to terminate a pregnancy between September 2000 and December 2018, 24 died from complications.

Some restrictions remain

The FDA left in place some restrictions, such as the need to use a certified pharmacy and requiring the prescribers to be certified. The ACLU said it was “disappointing that the FDA fell short of repealing all of its medically unnecessary restrictions on mifepristone, and these remaining obstacles should also be lifted.”

The organization sued the U.S. government on behalf of a Hawaii doctor and several professional health care associations in 2017, challenging the restrictions that it said limited access to medication abortion.

Medication abortion involves two drugs, taken over a day or two. The first, mifepristone, blocks the pregnancy-sustaining hormone progesterone. The second, misoprostol, induces uterine contractions.
…

A panel of outside advisers to the U.S. Centers for Disease Control and Prevention on Thursday voted to recommend that Americans choose one of the other two authorized COVID-19 vaccines over Johnson & Johnson’s shot because of the rare but sometimes fatal cases of blood clotting.

The CDC’s Advisory Committee on Immunization Practices voted unanimously on the recommendation. The regulator still needs to sign off on the guidance.

Cases of thrombosis with thrombocytopenia syndrome (TTS), which involves blood clots accompanied by a low level of platelets, have previously been reported in recipients of the J&J vaccine. The highest reporting rates are in women under 50.

The CDC said that the rate of such incidents is higher than previously estimated in both women and men.

At least nine people have died following the blood clotting incidents in the United States, the CDC has said.

Members of the panel also said J&J’s vaccine is less effective in preventing COVID-19 than the other two authorized vaccines.

In a presentation to the committee, a leading J&J vaccine scientist said the vaccine generates a strong and long-lasting immune response with just a single shot.

“In the setting where many people do not return for a second dose or a booster, the durability of the single-shot Johnson & Johnson vaccine as a primary regimen could make a crucial difference in saving lives in the U.S. and around the globe,” J&J’s Dr. Penny Heaton said in the presentation.

J&J’s vaccine uses a technology based on a modified version of an adenovirus to spur immunity in recipients, while the other two authorized vaccines use messenger RNA technology.

J&J’s one-dose vaccine received emergency use authorization in March. In April, U.S. regulators paused administering the vaccine for 10 days to investigate the blood clotting.

A CDC scientist said on Thursday that the rate of deaths from TTS did not decrease after the pause in April.

Fewer Americans have received the J&J shot than the other two vaccines — by a significant margin. Out of more than 200 million fully vaccinated people in the United States, around 16 million received J&J’s vaccine, according to CDC data.
…

NASA touches the sun and looks to the future by traveling back through time. Plus, Japanese tourists visit the ISS, and a space-travel pioneer’s daughter follows in her father’s flying footsteps. VOA’s Arash Arabasadi brings us the Week in Space.
…

Scientists in Hong Kong say the omicron variant of the coronavirus multiplies much faster in the airway passages, which could explain how the variant is spreading so fast around the globe.

A preliminary report by a team of researchers at the University of Hong Kong says laboratory experiments on tissue samples show omicron grows about 70 times faster than delta in the bronchus, the main tubes from the windpipe to the lungs.

The study also found that omicron grows 10 times slower in lung tissues than the original version, which could indicate a lower chance of a severe illness.

Lead researcher Michael Chan Chi-wai cautions that the severity of disease is not only determined by how quickly the virus replicates, but also by each person’s immune response to the infection, which could evolve into a life-threatening illness.

Dr. Chan adds that “by infecting many more people, a very infectious virus may cause more severe disease and death even though the virus itself may be less pathogenic.”

He says along with recent studies showing omicron can “partially escape immunity” from vaccines and previous infection, “the overall threat from the omicron variant is likely to be very significant.”

Omicron has now been detected in nearly 80 countries since it was first identified in southern Africa back in November.  Indonesia and New Zealand are the latest countries to report their first confirmed case of the virus.

On the vaccine front, an advisory panel with the Centers for Disease Control and Prevention will meet Thursday to discuss imposing limits on the single-shot Johnson & Johnson vaccine because of continued side effects.

The vaccine has been linked to a rare yet serious blood clotting disorder that occurs predominantly among women. At least six women out of the 16 million U.S. citizens who have received the Johnson & Johnson vaccine have been diagnosed with the disorder, including one woman who died.

The blood clotting disorder first emerged in April, soon after the vaccine began to be administered across the U.S., prompting federal health officials to suspend its use for several days while a safety review was conducted. Regulators added a warning about the potential for blood clots on the vaccine’s label, but concluded that its benefits outweighed the risks.

The Johnson & Johnson vaccine trails well behind the two-dose Pfizer and Moderna vaccines in terms of demand, both as an initial dose or a booster shot.

Some information for this report came from Reuters. 
…

Airbus is set to deliver the final A380 superjumbo to Dubai’s Emirates on Thursday, marking the end of a 14-year run that gave Europe an instantly recognized symbol across the globe but failed to fulfil the commercial vision of its designers. 

Production of the world’s largest airliner — capable of seating 500 people on two decks together with perks like showers in first class — has ended after 272 were built compared with the 1,000 or more once predicted. 

Airbus, a planemaking conglomerate drawn together from separate entities in Britain, France, Germany and Spain to carry out their brainchild of mega-jets to beat congestion, pulled the plug in 2019 after airlines went for smaller, leaner models. 

Thursday’s handover is expected to be low key, partly because of COVID restrictions and also because Airbus is these days focusing its PR on environmental benefits of smaller jets. 

That’s in stark contrast to the spectacular light show that revealed the new behemoth in front of European leaders in 2005. 

Emirates is by far the largest buyer and still believes in the superjumbo’s ability to lure passengers. Even though no more A380s will be built, it will keep flying them for years. Many airlines disagree and have axed the A380 during the pandemic. 

Airline president Tim Clark refuses to bow to sceptics who say the days of spacious four-engined jets like the A380 are numbered as an airline seat becomes a commodity like any other. 

“I don’t share that view at all … And I still believe there is a place for the A380,” Clark recently told reporters. 

“Technocrats and accountants said it was not fit for purpose … That doesn’t resonate with our travelling public. They absolutely love that airplane,” he said. 

Shower talks

 The A380’s demise left deserted one of the world’s largest buildings, a 122,500-square-metre assembly plant in Toulouse. 

Airbus plans to use part of it to build some of the bread-and-butter narrowbody models that dominate sales like a deal with Qantas announced earlier on Thursday. 

But it is in Hamburg that some of the most striking features of the A380 evolved. 

Clark recalled how he huddled with Airbus developers in northern Germany to persuade Airbus chiefs in France to pay for the engineering needed to make in-flight showers a reality. 

“There was a lot of arm-folding and my friends in France were a little circumspect,” Clark said. 

“I had to sit with friends in the development unit in Hamburg having to build the showers, and then asked Toulouse management to see how it could be done, and so they bought in.” 

That innovation generated headlines but did not translate into sales needed to keep the A380 going. 

The plane was designed in the 1990s when travel demand was soaring and China offered seemingly unlimited potential. 

By the time the first delivery came in 2007, the plane was more than two years late. And when Emirates got its first A380 a year later, the emerging financial crisis was already forcing analysts to trim their forecasts for the biggest jets. 

Boeing was meanwhile capturing orders for a revolutionary new 787 Dreamliner, to be followed by the Airbus A350. 

“There was a slowing down of appetite and enthusiasm. We didn’t share that view; we put this great [A380] aircraft to work,” Clark said on the sidelines of an airlines meeting. 

“We have what I think is one of the most beautiful aircraft ever flown.” 
…

The Israeli government on Wednesday said it was donating 1 million coronavirus vaccines to the U.N.-backed COVAX program.

The Foreign Ministry said the AstraZeneca vaccines would be transferred in the coming weeks, a decision that was part of Israel’s strengthening ties with the African countries.

“I am delighted that Israel can contribute and be a partner in eradicating the pandemic around the world,” said Foreign Minister Yair Lapid.

The announcement said the vaccines would reach close to a quarter of African countries, though it did not provide a list. Israel has close ties with a number of African nations, including Kenya, Uganda and Rwanda. Israel also established relations with Sudan last year as part of a series of U.S.-brokered accords.

COVAX is a global initiative that aims to provide coronavirus vaccines to poorer nations. Wealthier countries have acquired the most of the world’s vaccine supplies, causing vast inequality in access to jabs.

Israel was one of the first countries to vaccinate its population. Early this year, it came under criticism for not sharing enough of its supplies with the Palestinians.

Since then, Israel has vaccinated tens of thousands of Palestinians who work in Israel and its settlements, and the Palestinians have procured vaccines from COVAX and other sources. 

 
…

The White House COVID-19 Response team Wednesday said early data indicates the omicron coronavirus variant is spreading in the U.S., but current vaccine boosters appear to be effective in fighting it.

CDC Director Rochelle Walensky said the variant is in 36 U.S. states and accounts for 3% of all U.S. COVID-19 cases, though it is higher in some areas, such as New York and New Jersey, where it may account for as much 13% of cases.

Walensky said while the vast majority — 96% — of U.S. cases are still caused by the delta variant, she said early data show the omicron variant spreads faster than delta, with cases doubling in about two days.

Walensky, along with White House Chief Medical Adviser Anthony Fauci and COVID-19 Response coordinator Jeff Zients, cited data showing being fully vaccinated along with a booster shot is the best way to fight off the new variant.

“Our booster vaccine regimens work against omicron,” Fauci said. “At this point, there is no need for a variant-specific booster.”

Walensky cited recent data from U.S. nursing homes showing unvaccinated or fully vaccinated residents without boosters were 10 times more likely to contract COVID-19 than residents fully vaccinated with boosters. Fauci cited the most real-world studies showing boosters can increase anti-body protection against omicron by as much as 35 times.

Zients cited CDC statistics showing an unvaccinated person is eight times more likely to be hospitalized and 14 times more likely to die from COVID-19 than a fully vaccinated person. He said a new study from the Yale University of Public Health shows the U.S. vaccination program prevented 10.3 million hospitalizations and saved 1.1 million lives.

The COVID-19 response coordinator said 14 million people received booster shots in the first two weeks of December, with 26 million total shots in arms during the same period. In total, the team reports more than 200 million U.S. residents are now fully vaccinated, and more than 55 million have received booster shots.

Some information in this report was provided by the Reuters news agency.
…

The Chinese telecom giant Huawei has consistently claimed it does not actively partner with the Chinese government in gathering intelligence on individuals within China, but a report by The Washington Post this week showing the company appears to have marketed surveillance technology to government customers calls the company’s assertions into question.

The report comes as major parts of the large company’s operations remain severely restricted by sanctions imposed by the United States under former President Donald Trump, which were renewed, and in some cases tightened, by President Joe Biden.

The newspaper obtained more than 100 PowerPoint presentations that were briefly posted to a public page of the company’s website. The trove of documents suggests the company was marketing various surveillance-related services, including voice recognition technology, location tracking and facial-recognition-based area surveillance.

The presentations indicate the company also marketed systems meant to monitor prisons, like those in which China is currently believed to be holding an untold number of Uyghurs in the Western province of Xinjiang. The system tracked prisoners’ labor productivity, as well as their time spent in reeducation classes and data that might indicate the effectiveness of those classes.

Additionally, the materials appeared to market workplace surveillance tools, meant to monitor employees’ workplace performance and to spot workers who spend time resting or using personal electronics on the clock.

Huawei denial

In a statement provided to VOA, a Huawei spokesperson said, “Huawei has no knowledge of the projects mentioned in The Washington Post report.”

It continued, “Like all other major service providers, Huawei provides cloud platform services that comply with common industry standards. Huawei does not develop or sell systems that target any specific group of people and we require our partners comply with all applicable laws, regulations and business ethics. Privacy protection is our top priority and we require that all parts of our business comply with all applicable laws and regulations in the countries and regions where we operate.”

The Post, in its article, noted the company’s official watermark appeared on the pages of the PowerPoint presentation, and that several included a page noting a “Huawei Technologies Co. Ltd.” copyright.

Electronic security experts said the revelation of the PowerPoint presentations linking Huawei to state security wasn’t surprising, despite the company’s denials.

“Huawei has been closely linked to the security services from the start,” Jim Lewis, senior vice president and director of the Strategic Technologies Program at the Center for Strategic and International Studies, told VOA.

Lewis said the warnings about the company have been coming from American officials since George W. Bush was president but had not been taken seriously until the past few years, when China became more aggressive about asserting itself on the world stage.

“What’s changed is the audience,” Lewis said. Between China’s and [Chinese President] Xi Jinping’s behavior, people are willing to hear now about the problems with Huawei in a way they weren’t before.”

Punishing sanctions

The United States has, for several years, been warning that Huawei represents a security risk to the interests of the U.S. and its allies. Despite the company’s claims to the contrary, U.S. officials say they believe the company has close ties to Chinese state security agencies and that its telecommunications products could be used to gather information on, or disrupt the activities of, China’s rivals.

Officials also point to a law in China that obligates private companies to cooperate with government agencies in the collection of data deemed important to state security.

In 2019 and 2020, the U.S. began aggressively moving against Huawei on a number of fronts.

The Trump administration fought against the company’s effort to market the networking equipment necessary to roll out 5G wireless technology. 5G is the next generation of mobile connectivity and is expected to greatly enhance the ability of internet-connected devices to communicate, facilitating everything from self-driving vehicles to remote surgery.

The U.S. declared, among other things, it would cease sharing intelligence with allies who allow Huawei to supply critical pieces of their nations’ telecommunications infrastructure, arguing the company presented too much of a security risk.

As a result, a number of countries have barred the company’s technology from their 5G systems and others, including Britain, have begun the expensive process of removing Huawei equipment that already had been installed.

Smartphone setback

Until recently, Huawei was one of the biggest sellers of smartphones in the world and enjoyed near-complete dominance in the Chinese market. Other sanctions levied against the company, however, have severely damaged that business.

The U.S. barred firms from licensing or selling the company technology critical to some of its products. That included Google, which in 2019 said it would no longer license its Android operating system — the world’s most popular — for use in new phones made by the company.

Intel and Qualcomm, two major makers of microchips, were banned from selling their most advanced technology to Huawei. The ban extended to contract chipmakers, like Taiwan Semiconductor Manufacturing Corp., the world’s largest.

The result has been a drastic decline in the sale of Huawei smartphones, both globally and within China.

“The core of their devices business was smartphones, and their market share has just continued to decline,” Ryan Reith, a vice president with International Data Corporation, told VOA.

Reith said the prospects for recovery do not look good for the company’s smartphone business.

“We don’t see any way that the brand itself turns around,” he said. “So, it’s probably on its way out.”
…

The U.S. space agency NASA says its Parker Solar Probe this week became the first spacecraft to enter the Sun’s atmosphere, also known as the corona. 

The space agency announced the news Tuesday at a press conference during a meeting of the American Geophysical Union in New Orleans. 

In a statement, NASA scientists said the probe actually entered the Sun’s corona April 18, but it took until now to get the data and examine it to confirm it had accomplished its mission. 

NASA said while the Sun doesn’t have a solid surface, it does have a superheated corona made of solar material bound to the Sun by gravity and magnetic forces. The point at which those forces are too weak to contain material ejected from the sun is considered the edge of the corona, an area scientists call the Alfvén critical surface. 

NASA says the Parker probe crossed this boundry about 13 million kilometers above the surface of the sun. Until they were able to examine the data from the probe, scientists were not exactly sure where the area was. 

The scientists say during the flyby, which lasted only a few hours, the solar probe passed into and out of the corona several times. The data it gathered in doing so proved what some had predicted — that the Alfvén critical surface isn’t shaped like a smooth ball, but has it has spikes and valleys that wrinkle the surface. 

The Parker Solar Probe was launched in 2018 and was intended to exactly what it is doing: flying closer to the sun than any spacecraft has done before. NASA scientists compare what the probe has accomplished to landing on the moon. As the mission continues, the agency says, it will help scientists uncover critical information about Earth’s closest star and its influence on the solar system. 

A paper on the achievement was also published Tuesday in the scientific journal Physical Review Letters. 

Some information for this report was provided by the Associated Press.
…

The head of the South African Medical Association says there is a major difference between the delta and omicron variants of the coronavirus and warns politicians against hyping the threat from the new strain.

Dr. Angelique Coetzee criticized Tuesday what she described as the “over-reaction” to the heavily mutated omicron variant by some European governments and cited Britain’s Boris Johnson, who she accused of creating “hysteria” about the new strain.

On Tuesday, the House of Commons approved the reimposition of pandemic restrictions, and the introduction of some new ones, because of rising omicron cases in the country, although Johnson faced a major rebellion by a third of his parliamentary party and relied on opposition parties for the vote.

Coetzee was one of the first medical practitioners in the world to raise the alarm about the new variant. Its genomic data was sequenced last month by scientists in Hong Kong, Botswana as well as South Africa. The emergence has contributed to pandemic alarm in Europe, where governments are already battling the delta strain and are racing to reimpose restrictions.

Coetzee told Britain’s Sky News that delta was heart-breaking and that her patients who contracted it were “extremely, extremely sick” and when opening the door to them “you just knew they were in trouble,” she explained.

But nearly a month into the omicron wave in South Africa, she says she has not seen similar grim scenes and that her omicron patients are suffering much milder symptoms. Apart from one, who had HIV and other comorbidities, none have died.

The British government’s medical advisers are predicting one million omicron infections by the end of the month, and although South Africa is seeing tens of thousands of new cases daily.

Coetzee cautions calm, saying Britain and other European countries are much better vaccinated than South Africa and in a better position to battle it. “Even if you get breakthrough infections, it’s mild cases,” she added, saying she understands the need to take precautionary measures but says, “don’t hype it up.”

Some scientists disagree with Coetzee.

The chief executive of Britain’s Health Security Agency told lawmakers Wednesday that omicron “is probably the most significant threat since the start of the pandemic.”

Dr. Jenny Harries said the new variant was much more transmissible than delta and the rapid spread of omicron would lead to a “staggering” number of COVID cases over the next few days. She delivered a series of dire warnings about the country’s health care system, although she added it was probably too early to tell how serious the scale of increasing infections across the world would turn out to be.

“The difficulty is that the growth of this virus, it has a doubling time which is shortening, i.e., it’s doubling faster, growing faster,” she said.

Governments across Europe are closely observing events unfolding in Britain for a sense of what may lie ahead for them as omicron spreads, and they are worried that reinfection rates from omicron are much higher than has been seen with earlier variants.

Restrictions and penalties 

More countries are adopting restrictions. Italy this week required negative tests from vaccinated visitors to the country. Portugal has a similar measure in place. Many European countries have a virtual lockdown for the unvaccinated and are scrambling to increase vaccine booster programs. And more governments, including Germany’s, are proposing or considering mandatory vaccines.

Austria and Italy already plan to impose hefty fines on eligible people who do not get vaccinated. 

People over 65 years old in France will be under effective lockdown from Wednesday, if they have not received a third vaccine booster dose.

France’s health pass will no longer be valid for the elderly who have not received a third dose, barring those who have not been boosted from visiting restaurants or cafes or taking intercity trains. They will also be prohibited from visiting cultural venues like cinemas or museums.

European Commission President Ursula von der Leyen warned Wednesday the European Union faces a double challenge, with a massive increase of delta cases in recent weeks and the threat of omicron looming. “We’re seeing an increasing number of people falling ill, a greater burden on hospitals and unfortunately, an increase in the number of deaths,” she told European Parliament lawmakers. 

“And what I’m concerned about is that we now [are] seeing the new variant omicron on the horizon, which is apparently even more infectious,” she added.

But as governments go into overdrive, some epidemiologists and virologists are echoing Angelique Coetzee. Professor Tim Spector, the head of Genetic Epidemiology at King’s College, London, says the “majority of symptoms are just like a common cold, so we’re talking about headaches, sore throat, runny nose, fatigue, and things like sneezing.” He added: “So, things like fever and cough and loss of smell are now actually in the minority of the symptoms that we’re seeing.”

Earlier this week, the first major study published into the new variant also suggested illness from omicron is less severe than from delta. The study of 78,000 omicron cases in South Africa found the risk of hospitalization is 29% lower compared with the Wuhan strain, and 23% lower than with delta. Far fewer people have been needing intensive care. Just 5% of omicron cases have been admitted to intensive care units compared to 22% of delta patients, the study shows.

The data for the study was compiled by Discovery Health, South Africa’s largest private health insurer, and the South Africa Medical Research Council. It noted omicron can evade vaccines more than earlier strains, but the study found vaccines are still holding up well, although there were high numbers of breakthrough infections in people who had been vaccinated.

Vaccine effectiveness against infection dropped from 80% to 33%, according to the study, but offered 70% protection against hospital admission. Boosters may also mitigate the reduction in vaccine effectiveness, according to the study. Some European scientists have cautioned, though, against reading too much into the South African study, saying that South Africa’s population is much younger and that demographic differences could alter medical outcomes.
…

African leaders have called on governments across the continent to invest more in healthcare to fight the coronavirus and future pandemics. The appeal came as the Africa Centers for Disease Control and Prevention and the African Union this week held the first Conference on Public Health in Africa.

Addressing the virtual meeting of African health workers and experts, Rwandan President Paul Kagame said governments could no longer ignore public health investment as the continent grapples with the COVID-19 pandemic. 

“There needs to be renewed commitment by government and national parliaments to increase domestic financing for health in Africa. This has been a priority for the African Union for several years but progress has not been fast enough. We cannot continue to rely on external funding for something so important for our future,” he said.

Twenty years ago in Abuja, Nigeria, African governments agreed to allocate 15% of their budgets to health care. Only two countries, Rwanda and South Africa, met the target. 

Africa has seen economic growth in the past few years but spending by governments on health has rarely increased. 

Health experts blame the lack of healthcare spending on low GDP growth, tax collections, and competing priorities. 

An Afrobarometer survey showed 46% of African citizens across 36 countries opposed paying more taxes to be used to improve healthcare. 

Across Africa, most health facilities are concentrated in urban areas, effectively cutting off millions from accessing advanced medical assistance. 

John Nkengasong, the head of the Africa Centers for Disease Control and Prevention, said the continent needs a new approach to raise health investment. 

“You all heard from our various leaders, political leaders, call for a new public health order that hinges on four things: strengthening public health institutions, workforce, expanding manufacturing on both vaccines, diagnostic and therapeutic, a respectful action-oriented partnership, which is all underpinned by the need to invest ourselves in supporting this domestic financing so that we can achieve these four goals,” he said.

African Union Commission Chairman Mousa Faki Mahamat pledged to support the development of health care systems that can deal with future challenges. 

“I would like to assure you today that African Union Commission stands firm in our resolve to bolster manufacturing capacity for the vaccine, diagnostic and therapeutics to build resilient health systems capable of detecting future health threats, and to build a finance mechanism that allows member states to respond efficiently and effectively to health needs of the continent,” he said.

According to the Brookings Institute, Africa needs funding models that encourage domestic resource mobilization and prioritization of health. 

For example, in 2019 Nigeria signed a $75 million financing agreement with the Bill and Melinda Gates Foundation to strengthen the country’s primary health care provision fund. 

Africa’s virtual conference on public health ends Thursday. 

 
…